Maurya et al. explored 111 MDS patients and reported an NPM1-mut frequency of 3.6%, with 50% of NPM1-mut patients showing an IPSS low risk and 50% an IPSS high risk and a reduced OS compared to MDS patients without NPM1 mutations [70]. The gene discussed is NPM1; the disease is myelodysplastic syndrome.